OriGen Biomedical is a leading producer of cryopreservation and cell culture products.

Our focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority.

OriGen Biomedical is a growing, privately-held medical device manufacturer founded in 1997 and headquartered in Austin, Texas. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. OriGen holds and maintains ISO 13485 and MDSAP certifications and is routinely audited by its certification body, regulatory authorities, and our customers.

Our distribution center serves to reduce the time to patient by providing stock products for quicker turnaround times out of the Netherlands.

Regulatory and Accreditation information can be found here.

READ ABOUT THE HISTORY OF ORIGEN

Our Vision

To be the supplier of choice for single-use disposables within cell and gene therapy and to support transformational therapies across the world.

Our Core Values

Our Core Values

At OriGen Biomedical, we believe in being an example of corporate social responsibility, demonstrating excellence in all aspects of our operations. We foster incremental innovation, providing unparalleled customer service while ensuring that advancement opportunities are based on merit. Our commitment to these values means that our work not only benefits our customers but also positively impacts our community and the world. Through our efforts, we strive to create a meaningful and lasting difference, upholding our dedication to making the world a better place.

User-Inspired Design Commitment

We strive to find product solutions that make your operations more intuitive, safer, and more efficient. Our engineers at OriGen will partner with you to create products that align with your lab practices, rather than requiring you to adjust your practices to fit the products. Our collaborative approach ensures that the solutions we provide are tailored to your specific needs. Contact OriGen for additional information on this process.

Quality Commitment

Product quality is our top priority. We design every product with one goal in mind: improving patient health. We understand how important our role is in your daily operations, which is why we prioritize consistently improving our operations to support your changing needs effectively and safely as you develop new therapies. OriGen holds and maintains ISO 13485 and MDSAP certifications and is routinely audited by its certification body, regulatory authorities, and our customers.

Customer Commitment

We offer superior products along with exceptional customer service. Our customer-centric approach involves actively listening to your needs and collaborating to develop tailored solutions. OriGen is not just another supplier; we are your dedicated partner, committed to delivering customized solutions aligned with your organization’s requirements. As our customer, you can be sure the same attention to detail has gone into every product with the OriGen Biomedical label.

Notable OriGen Milestones

2023

Austin American-Statesman Names OriGen a Winner of the Greater Austin Top Workplaces 2023 Award

The list is based solely on employee feedback gathered through a third-party survey. Read more »

2022

OriGen Celebrates 25 Years in Business

OriGen looks back and celebrates the people, partnerships, and places that helped us become the company we are today. Read more »

2022

TissueVault™ Bag FDA 510(k) Exempt

The OriGen Biomedical® TissueVault Freezing Bags are intended to freeze cells and tissues. Read more »

2022

OriGen Receives CE Mark and Globally Launches CryoStore FLEX Freezing Bag

OriGen has been granted CE mark approval for the CryoStore FLEX Freezing Bag product line, indicating its compliance with specific requirements of relevant EU Medical Device Directives. Read more »

2021

OriGen Biomedical Appears on the Inc. 5000 List

For the 7th Time, OriGen Biomedical Appears on the Inc. 5000 List – Ranking No. 2860 with 3-Year Revenue Growth of 137.7% Read more »

2019

Beth San Segundo Becomes President & CEO

Richard Martin, OriGen Founder and former President/CEO, transitioning to the position of OriGen’s Chairman of the Board. Read more »

2019

Granted MDD EU Expanded Access until 2024

2019

CryoStore Multi-Chamber Bag 510(k) Received

The United States Food and Drug Administration (FDA) cleared the CryoStore Multi-Chamber Freezing Bag through the 510(k) process for the indication of freezing blood components. Read more »

2017

Opened Direct EU Distribution Channel in the Netherlands

2016

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2016 Inc. 5000 for its Sixth Consecutive Year Read more »

2015

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2015 Inc. 5000 for its Fifth Consecutive Year Read more »

2014

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2014 Inc. 5000 for its Fourth Consecutive Year Read more »

2013

OriGen Biomedical Makes Texas A&M University’s Aggie 100

The Aggie 100 is an annual award that recognizes the 100 fastest-growing companies in the world that are owned or led by Texas A&M University alumni, commonly known as “Aggies.” OriGen ranked #97 Read more »

2013

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2013 Inc. 5000 for its Third Consecutive Year

2012

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2012 Inc. 5000 for its Second Year Read more »

2012

Expanded Burleson Facility

Added two additional clean rooms; one for sterile fill and one for product manufacture. Read more »

2011

OriGen Biomedical Appears on the Inc. 5000 List

OriGen Biomedical Ranks in 2011 Inc. 5000 for its First Time

2010

Evolve Cell Culture Bag FDA 510(k) Exempt

The Evolve Cell Culture Bag is intended for use in cell culture. Read more »

2010

Moved to Burleson Facility: 1 Cleanroom, 1 Sterile Fill Suite

OriGen moves to its current Headquarters at 7000 Burleson Rd, Bldg D Austin, Texas  78744. Read more »

2009

CE Mark for CryoPur™ DMSO Received

OriGen Biomedical® DMSO and DMSO formulations are intended for the preservation of stem cells and blood components in a frozen state. Read more »

2007

Chinese NMMA CryoStore Clearance Received

2007

CE Mark for TissueVault™ Bag Received

The OriGen Biomedical® TissueVault Freezing Bags are intended to freeze cells and tissues. Read more »

2003

CE Mark for CryoStore Bag Received

The CryoStore bag is designed to freeze blood components. Read more »

2003

CE Mark for O-Wrap™ Bag Received

The OriGen Biomedical® O-Wrap Bag is intended to contain other freezing bags to protect them in long-term frozen storage. The O-Wrap bag is suitable for direct use in liquid nitrogen freezing applications. Read more »

2003

CE Mark for PermaLife™ Bag Received

The OriGen Biomedical® PermaLife bag is intended for use in cell culture and in protecting, storing, and freezing cells and tissues. Read more »

2003

CryoStore Bag 510(k) Received

The United States Food and Drug Administration (FDA) cleared the CryoStore Freezing Bag through the 510(k) process for the indication of freezing blood components. Read more »

1997

OriGen Biomedical, Inc. Founded

Richard Martin establishes OriGen in Austin, TX.
Read more »

1990

PermaLife™ Bag 510(k) Received

The United States Food and Drug Administration (FDA) cleared the PermaLife Cell Culture Bag through the 510(k) process for the intended use in cell culture and in protecting, storing, and freezing cells and tissues.  Read more »

OriGen Biomedical® is a registered trademark of OriGen Biomedical, Inc.